CNCR
Loncar Cancer Immunotherapy ETF
$14.11
-0.25 (-1.74%)
Currency in USD / Last Updated: 4/19/2024
| Category | Health |
|---|---|
| Market Cap | 20.189M |
| 52 Week High | 17.84 |
| 52 Week Low | 9.24 |
Customize MutualFund.com
Log in or sign up to get started.
Expense Details
| Deferred | 0 |
|---|---|
| 12b-1 | 0 |
| Front Load | 0 |
| Initial Purchase Amount | 0 |
| Redeption Fee | 0 |
| Prospectus | 0.0079 |
Overview
| 52 Week High | 17.84 |
|---|---|
| 52 Week Low | 9.24 |
| Market Cap | 20.19M |
| Shares Outstanding | 1.43M |
| Income Dividend Yield | 0.00% |
| Long Term Dividend Yield | 0.00% |
| Short Term Dividend Yield | 0.00% |
| 52 Week Yield (All) | 0.00% |
Returns Annualized
| One Day | -98.81% |
|---|---|
| Five Days | -99.44% |
| One Months | -74.76% |
| Three Months | 25.95% |
| Six Months | 109.53% |
| Nine Months | 8.82% |
| One Year | 9.39% |
| Three Years | -19.39% |
| Five Years | -4.69% |
| Ten Years | -999 |
| YTD | 16.66% |
| Since Inception | -5.23% |
Returns Total
| One Day | -1.74% |
|---|---|
| Five Days | -9.78% |
| One Month | -11.31% |
| Three Months | 5.93% |
| Six Months | 44.27% |
| Nine Months | 6.57% |
| One Year | 9.38% |
| Three Years | -47.59% |
| Five Years | -21.31% |
| Ten Years | -999 |
| YTD | 4.75% |
| Since Inception | -36.63% |
Yearly Returns
| 2024 | 4.75% |
|---|---|
| 2023 | -1.89% |
| 2022 | -42.31% |
| 2021 | -19.15% |
| 2020 | 38.95% |
| 2019 | 24.22% |
| 2018 | -20.65% |
| 2017 | 13.61% |
| 2016 | -25.63% |
| 2015 | 14.25% |
Risk against SP-DA
| Alpha | -27.03% |
|---|---|
| Beta | 1.93 |
| Correlation | 70.00% |
| Downside Deviation | 7.79% |
| Coefficient of determination | 49.01% |
| Standard Deviation | 9.40% |
| Sharpe Ratio | -0.37 |
| Sortino | -1.55 |
| Treynor | 2.08 |
| Ulcer Index | 14.38 |
| Ulcer Performance Index | -0.84 |